TRIAL OF NIFENAZONE ("THYLIN").
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D000983:Antipyrine / Q000031:analogs & derivatives; D001168:Arthritis; D001172:Arthritis, Rheumatoid; D009536:Niacinamide / Q000031:analogs & derivatives; D010003:Osteoarthritis; D010113:Oxyphenbutazone; D010600:Pharmacology; D010653:Phenylbutazone; D012698:Serologic Tests; D013166:Spondylitis; D013167:Spondylitis, Ankylosing; D014116:Toxicology
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D009536:Niacinamide; C005249:nifenazone; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D000983:Antipyrine
ANALGESICS AND ANTIPYRETICS; ARTHRITIS, RHEUMATOID; OSTEOARTHRITIS; OXYPHENBUTAZONE; PHARMACOLOGY; PHENYLBUTAZONE; SERODIAGNOSIS; SPONDYLITIS, ANKYLOSING; TOXICOLOGIC REPORT